A response letter to comments on "Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016"
Eur J Cancer
.
2020 Nov:140:165-166.
doi: 10.1016/j.ejca.2020.09.005.
Epub 2020 Oct 3.
Authors
Elise Deluche
1
,
Alison Antoine
2
,
Thomas Bachelot
3
,
Mathieu Robain
4
,
David Perol
2
,
Suzette Delaloge
5
Affiliations
1
Department of Medical Oncology, CHU de Limoges, France.
2
Department of Biostatistics, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008, Lyon, France.
3
Department of Medical Oncology, Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, 69008, Lyon, France.
4
Department of Research and Development, R&D Unicancer, 101 Rue de Tolbiac, 75654, Paris, France.
5
Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. Electronic address:
[email protected]
.
PMID:
33020000
DOI:
10.1016/j.ejca.2020.09.005
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Breast Neoplasms*
Cohort Studies
Female
Humans
Receptor, ErbB-2
Substances
Receptor, ErbB-2